Ultibro Breezhaler (Indacaterol/Glycopyrronium Bromide) is a prescription medication used as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD. This medication contains two active substances, Indacaterol 85mcg and glycopyrronium 43 mcg. Ultibro Breezhaler is available as capsules containing a powder for inhalation. The recommended dose is one inhalation once a day of the powder content of a single capsule. This medication is taken at the same time each day using the Ultibro Breezhaler device.
Manufacturer Information
We currently have the brand from Canada manufactured by Novartis. This medication is available in the strength of 110mcg/50mcg capsules.
Common side effects include:
• Cavities;
• Cough;
• Dizziness;
• Muscle or joint pain;
• Sneezing, runny or stuffy nose, fever;
• Sore throat;
• Pain in the arms or legs
Serious side effects include:
• Chest pain;
• High blood pressure;
• Feeling tired;
• Insomnia;
• Tingling or numbness
Do not use Ultibro Breezhaler if you have a severe allergy to Indacaterol maleate or Glycopyrronium bromide or any other component of the Ultibro Breezhaler. This medication should not be used to treat sudden or severe symptoms of COPD such as sudden shortness of breath or wheezing or to treat asthma. Ultibro Breezhaler should not be used in children under than 18 years old. Before you start taking this medication, inform your doctor about your medical condition and about all the medications you are currently taking including OTC and herbal medications. There may be an interaction between Ultibro Breezhaler and other medications such as propranolol, timolol, ketoconazole, ritonavir, erythromycin, verapamil, etc.